Literature DB >> 19936895

A method for robust model order reduction in pharmacokinetics.

Aristides Dokoumetzidis1, Leon Aarons.   

Abstract

We present a Bayesian automated method to reduce by lumping, a large system described by differential equations which takes into account parameter variability. Model reduction is a potentially useful tool to simplify large systems but suffers from lack of robustness over the model parameter values. With the present method we address this problem by incorporating a prior parameter distribution in the determination of the optimal lumping scheme in a Bayesian manner. Applications of this method may include PBPK models for the drug distribution and/or Systems Biology models for the drug action. The method builds on our previously published algorithm for lumping that works stepwise, reducing the system's dimension by one at each step and where each successive step is conditional to the previous ones. We applied the methodology to a PBPK model for barbiturates taken from the literature. An arbitrary variability of 20% CV was added to the nominal reported parameter values. The Bayesian method performed better than the method which ignored the parameter variability, producing a lumping scheme which, while not optimal for any parameter value, was optimal on average. On the other hand the simple, non-Bayesian method produced a lumping scheme which while optimal for the nominal parameter values, was very poor for most other values within the prior distribution. Further, we discuss the generality of a lumping strategy to reduce a model and we argue that this is more powerful than elimination of states, with the latter being almost a special case of lumping.

Mesh:

Substances:

Year:  2009        PMID: 19936895     DOI: 10.1007/s10928-009-9141-9

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  9 in total

1.  Simplification of Mathematical Models of Chemical Reaction Systems.

Authors:  Miles S. Okino; Michael L. Mavrovouniotis
Journal:  Chem Rev       Date:  1998-04-02       Impact factor: 60.622

2.  Reducing whole body physiologically based pharmacokinetic models using global sensitivity analysis: diazepam case study.

Authors:  Ivelina Gueorguieva; Ivan A Nestorov; Malcolm Rowland
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-12-20       Impact factor: 2.745

3.  Lumping in pharmacokinetics.

Authors:  Céline Brochot; János Tóth; Frédéric Y Bois
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-12       Impact factor: 2.745

4.  Proper lumping in systems biology models.

Authors:  A Dokoumetzidis; L Aarons
Journal:  IET Syst Biol       Date:  2009-01       Impact factor: 1.615

5.  Lumping of whole-body physiologically based pharmacokinetic models.

Authors:  I A Nestorov; L J Aarons; P A Arundel; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1998-02

6.  Quantitative structure-pharmacokinetics relationships: I. Development of a whole-body physiologically based model to characterize changes in pharmacokinetics across a homologous series of barbiturates in the rat.

Authors:  G E Blakey; I A Nestorov; P A Arundel; L J Aarons; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1997-06

7.  Robust simplifications of multiscale biochemical networks.

Authors:  Ovidiu Radulescu; Alexander N Gorban; Andrei Zinovyev; Alain Lilienbaum
Journal:  BMC Syst Biol       Date:  2008-10-14

8.  The subtle business of model reduction for stochastic chemical kinetics.

Authors:  Dan T Gillespie; Yang Cao; Kevin R Sanft; Linda R Petzold
Journal:  J Chem Phys       Date:  2009-02-14       Impact factor: 3.488

9.  Finding multiple target optimal intervention in disease-related molecular network.

Authors:  Kun Yang; Hongjun Bai; Qi Ouyang; Luhua Lai; Chao Tang
Journal:  Mol Syst Biol       Date:  2008-11-04       Impact factor: 11.429

  9 in total
  9 in total

1.  Workflow for generating competing hypothesis from models with parameter uncertainty.

Authors:  David Gomez-Cabrero; Albert Compte; Jesper Tegner
Journal:  Interface Focus       Date:  2011-03-30       Impact factor: 3.906

Review 2.  Combining the 'bottom up' and 'top down' approaches in pharmacokinetic modelling: fitting PBPK models to observed clinical data.

Authors:  Nikolaos Tsamandouras; Amin Rostami-Hodjegan; Leon Aarons
Journal:  Br J Clin Pharmacol       Date:  2015-01       Impact factor: 4.335

3.  Understanding and reducing complex systems pharmacology models based on a novel input-response index.

Authors:  Jane Knöchel; Charlotte Kloft; Wilhelm Huisinga
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-12-14       Impact factor: 2.745

4.  Development of a Novel Simplified PBPK Absorption Model to Explain the Higher Relative Bioavailability of the OROS® Formulation of Oxybutynin.

Authors:  Andrés Olivares-Morales; Avijit Ghosh; Leon Aarons; Amin Rostami-Hodjegan
Journal:  AAPS J       Date:  2016-09-08       Impact factor: 4.009

5.  Scale reduction of a systems coagulation model with an application to modeling pharmacokinetic-pharmacodynamic data.

Authors:  A Gulati; G K Isbister; S B Duffull
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2014-01-08

6.  Automated proper lumping for simplification of linear physiologically based pharmacokinetic systems.

Authors:  Shan Pan; Stephen B Duffull
Journal:  J Pharmacokinet Pharmacodyn       Date:  2019-06-21       Impact factor: 2.745

7.  Reduction of a Whole-Body Physiologically Based Pharmacokinetic Model to Stabilise the Bayesian Analysis of Clinical Data.

Authors:  Thierry Wendling; Nikolaos Tsamandouras; Swati Dumitras; Etienne Pigeolet; Kayode Ogungbenro; Leon Aarons
Journal:  AAPS J       Date:  2015-11-04       Impact factor: 4.009

8.  Application of a Bayesian approach to physiological modelling of mavoglurant population pharmacokinetics.

Authors:  Thierry Wendling; Swati Dumitras; Kayode Ogungbenro; Leon Aarons
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-08-01       Impact factor: 2.745

9.  Model reduction in mathematical pharmacology : Integration, reduction and linking of PBPK and systems biology models.

Authors:  Thomas J Snowden; Piet H van der Graaf; Marcus J Tindall
Journal:  J Pharmacokinet Pharmacodyn       Date:  2018-03-26       Impact factor: 2.745

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.